Comparisons of EQ-5D-Y and PedsQL in pediatric patients with mild-to-moderate chronic kidney disease in longitudinal analyses

Abstract Objective To characterize longitudinal changes and correlations between the measures of EQ-5D-Y and generic PedsQL and their associations with clinical changes in children and adolescents with mild-to-moderate chronic kidney disease (CKD). Methods Participants were recruited from January 20...

Full description

Bibliographic Details
Main Authors: Chien-Ning Hsu, You-Lin Tain, Pei-Chen Lu, Hsiang-Wen Lin
Format: Article
Language:English
Published: BMC 2023-10-01
Series:Health and Quality of Life Outcomes
Subjects:
Online Access:https://doi.org/10.1186/s12955-023-02197-9
_version_ 1797647202218147840
author Chien-Ning Hsu
You-Lin Tain
Pei-Chen Lu
Hsiang-Wen Lin
author_facet Chien-Ning Hsu
You-Lin Tain
Pei-Chen Lu
Hsiang-Wen Lin
author_sort Chien-Ning Hsu
collection DOAJ
description Abstract Objective To characterize longitudinal changes and correlations between the measures of EQ-5D-Y and generic PedsQL and their associations with clinical changes in children and adolescents with mild-to-moderate chronic kidney disease (CKD). Methods Participants were recruited from January 2017 to September 2021 in a medical center in Taiwan. Both instruments were administered in their initial visits and every 6-month subsequent visits. Spearman’s Rho (ρ) was used to assess correlations between the scores of EQ-5D-Y and PedsQL measures in longitudinal changes. Cohen’s effect size (ES) was used to evaluate the changes of scores/subscales over time. In addition, factors associated with longitudinal changes in the score/subscales were explored. Results A total of 121 participants were enrolled, and 83 with ≥ 3 HRQOL measures during the 3.5 years follow-up were assessed their changes of HRQOL measures. The correlations (ρ > 0.3) appeared between the changes in the visual analog scale (VAS) of EQ-5D-Y and emotional and social subscales of PedsQL. ES was small (< 0.5) in the VAS and level-sum-score (LSS) of EQ-5D-Y scores for the clinical changes in comorbidities, while some PedsQL subscales were medium to high (0.5–0.8 or > 0.8). Hypertension, mineral bone disorder/anemia, and hyperuricemia associated with the changes in both HRQOL scores were varied by their various domains. Conclusion Both EQ-5D-Y and PedsQL of HRQOL measures were responsive to worsened childhood CKD-related comorbidities during the follow-up; however, convergent validity between them was limited in some domains. The LSS of EQ-5D-Y showed greater changes than the VAS by comorbidity status; further comparison with utility weight is needed to determine the better performance of EQ-5D-Y.
first_indexed 2024-03-11T15:12:52Z
format Article
id doaj.art-81ae7aaf35a346189e65d046a31d8be4
institution Directory Open Access Journal
issn 1477-7525
language English
last_indexed 2024-03-11T15:12:52Z
publishDate 2023-10-01
publisher BMC
record_format Article
series Health and Quality of Life Outcomes
spelling doaj.art-81ae7aaf35a346189e65d046a31d8be42023-10-29T12:37:11ZengBMCHealth and Quality of Life Outcomes1477-75252023-10-0121111310.1186/s12955-023-02197-9Comparisons of EQ-5D-Y and PedsQL in pediatric patients with mild-to-moderate chronic kidney disease in longitudinal analysesChien-Ning Hsu0You-Lin Tain1Pei-Chen Lu2Hsiang-Wen Lin3Department of Pharmacy, Kaohsiung Chang Gung Memorial HospitalDivision of Pediatric Nephrology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung UniversityDivision of Pediatric Nephrology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung UniversitySchool of Pharmacy and Graduate Institute, College of Pharmacy, China Medical UniversityAbstract Objective To characterize longitudinal changes and correlations between the measures of EQ-5D-Y and generic PedsQL and their associations with clinical changes in children and adolescents with mild-to-moderate chronic kidney disease (CKD). Methods Participants were recruited from January 2017 to September 2021 in a medical center in Taiwan. Both instruments were administered in their initial visits and every 6-month subsequent visits. Spearman’s Rho (ρ) was used to assess correlations between the scores of EQ-5D-Y and PedsQL measures in longitudinal changes. Cohen’s effect size (ES) was used to evaluate the changes of scores/subscales over time. In addition, factors associated with longitudinal changes in the score/subscales were explored. Results A total of 121 participants were enrolled, and 83 with ≥ 3 HRQOL measures during the 3.5 years follow-up were assessed their changes of HRQOL measures. The correlations (ρ > 0.3) appeared between the changes in the visual analog scale (VAS) of EQ-5D-Y and emotional and social subscales of PedsQL. ES was small (< 0.5) in the VAS and level-sum-score (LSS) of EQ-5D-Y scores for the clinical changes in comorbidities, while some PedsQL subscales were medium to high (0.5–0.8 or > 0.8). Hypertension, mineral bone disorder/anemia, and hyperuricemia associated with the changes in both HRQOL scores were varied by their various domains. Conclusion Both EQ-5D-Y and PedsQL of HRQOL measures were responsive to worsened childhood CKD-related comorbidities during the follow-up; however, convergent validity between them was limited in some domains. The LSS of EQ-5D-Y showed greater changes than the VAS by comorbidity status; further comparison with utility weight is needed to determine the better performance of EQ-5D-Y.https://doi.org/10.1186/s12955-023-02197-9PediatricsChronic kidney diseaseHealth-related quality of lifeEQ-5D-YPedsQLLongitudinal analysis
spellingShingle Chien-Ning Hsu
You-Lin Tain
Pei-Chen Lu
Hsiang-Wen Lin
Comparisons of EQ-5D-Y and PedsQL in pediatric patients with mild-to-moderate chronic kidney disease in longitudinal analyses
Health and Quality of Life Outcomes
Pediatrics
Chronic kidney disease
Health-related quality of life
EQ-5D-Y
PedsQL
Longitudinal analysis
title Comparisons of EQ-5D-Y and PedsQL in pediatric patients with mild-to-moderate chronic kidney disease in longitudinal analyses
title_full Comparisons of EQ-5D-Y and PedsQL in pediatric patients with mild-to-moderate chronic kidney disease in longitudinal analyses
title_fullStr Comparisons of EQ-5D-Y and PedsQL in pediatric patients with mild-to-moderate chronic kidney disease in longitudinal analyses
title_full_unstemmed Comparisons of EQ-5D-Y and PedsQL in pediatric patients with mild-to-moderate chronic kidney disease in longitudinal analyses
title_short Comparisons of EQ-5D-Y and PedsQL in pediatric patients with mild-to-moderate chronic kidney disease in longitudinal analyses
title_sort comparisons of eq 5d y and pedsql in pediatric patients with mild to moderate chronic kidney disease in longitudinal analyses
topic Pediatrics
Chronic kidney disease
Health-related quality of life
EQ-5D-Y
PedsQL
Longitudinal analysis
url https://doi.org/10.1186/s12955-023-02197-9
work_keys_str_mv AT chienninghsu comparisonsofeq5dyandpedsqlinpediatricpatientswithmildtomoderatechronickidneydiseaseinlongitudinalanalyses
AT youlintain comparisonsofeq5dyandpedsqlinpediatricpatientswithmildtomoderatechronickidneydiseaseinlongitudinalanalyses
AT peichenlu comparisonsofeq5dyandpedsqlinpediatricpatientswithmildtomoderatechronickidneydiseaseinlongitudinalanalyses
AT hsiangwenlin comparisonsofeq5dyandpedsqlinpediatricpatientswithmildtomoderatechronickidneydiseaseinlongitudinalanalyses